Annapolis Financial Services’s MacroGenics MGNX Stock Holding History

Annapolis Financial Services’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-230	Closed	-$5K	–	442
2020 Q4	$5K	Buy	+230	New	+$5.29K	﹤0.01%	302

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Annapolis Financial Services's MGNX Position: Q1 2021 in Review

Annapolis Financial Services sold out of MacroGenics (MGNX) in Q1 2021, closing a stake of 230 shares — an estimated $5K sold.

Annapolis Financial Services first reported a position in MGNX in Q4 2020 and held it in 1 quarter. The position peaked at $5K in Q4 2020. 173 funds tracked by Wall St. Rank hold MGNX as of Q1 2021.

Annapolis Financial Services reported no remaining MacroGenics position as of Q1 2021 after selling out during the quarter.
Annapolis Financial Services sold 230 MacroGenics shares in Q1 2021, an estimated $5K.
Annapolis Financial Services first reported a position in MacroGenics in Q4 2020 and held it in 1 quarter.
Annapolis Financial Services's MacroGenics position peaked at $5K in Q4 2020.
173 funds tracked by Wall St. Rank held MacroGenics as of Q1 2021.

Based on Annapolis Financial Services's 13F filing for Q1 2021, filed 6 May 2021.